| Category: |
Primary Antibodies |
| Target: |
SPINK5 |
| Immunogen: |
See techfile |
| Clonality: |
Polyclonal |
| Raised in: |
Rabbit |
| Reactivity: |
Mouse, Rat, Human |
| Purification: |
Affinity purified |
| Applications: |
WB (for other see techfile or inquire) |
| Stock availability: |
Shipped within 5-10 working days |
| Storage conditions: |
Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings: |
This product is for research use only |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24° |
| Gene target: |
SPINK5 |
| Short name: |
Anti-SPINK5 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Kazal classification 5 (Antibody to), antibody to-serine peptidase inhibitor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BT, Extracellular, Kazal type 5, LEKTI and LETKI and NETS and NS and VAKTI, SPINK5 and IDBG-52343 and ENSG00000133710 and 11005, Spink5 and IDBG-144109 and ENSMUSG00000055561 and 72432, peptidase inhibitor activity, this GO :0004867 and serine-type endopeptidase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005789 and endoplasmic reticulum membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0005938 and cell cortex and cellular component this GO :0009913 and epidermal cell differentiation and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0016525 and negative regulation of angiogenesis and biological process this GO :0030155 and regulation of cell adhesion and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030414 and peptidase inhibitor activity and molecular function this GO :0030855 and epithelial cell differentiation and biological process this GO :0035315 and hair cell differentiation and biological process this GO :0042640 and anagen and biological process this GO :0045087 and innate immune response and biological process this GO :0045580 and regulation of T cell differentiation and biological process this GO :0045861 and negative regulation of proteolysis and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050777 and negative regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0097209 and epidermal lamellar body and cellular component this GO :1902572 and negative regulation of serine-type peptidase activity and biological process, this GO :0004867 : serine-type endopeptidase inhibitor activity, this GO :0004867 : serine-type endopeptidase inhibitor activity and also this GO :0005515 : protein binding and also this GO :0030414 : peptidase inhibitor activity, this GO :0005515 : protein binding, this GO :0030414 : peptidase inhibitor activity, 43608 and IDBG-646193 and ENSBTAG00000019140 and 526637, serine peptidase inhibitor |
| Identity: |
15464 |
| Gene: |
SPINK5 |
More about : SPINK5 |
| Long gene name: |
Kazal type 5 , serine peptidase inhibitor |
| Synonyms gene name: |
Kazal type 5 , serine protease inhibitor |
| Synonyms: |
VAKTI LEKTI LETKI NETS NS FLJ21544 FLJ97536 FLJ97596 FLJ99794 DKFZp686K19184 |
| Synonyms name: |
lymphoepithelial Kazal-type-related inhibitor |
| Locus: |
5q32 |
| Discovery year: |
2001-03-30 |
| GenBank acession: |
AJ228139 |
| Entrez gene record: |
11005 |
| Pubmed identfication: |
10419450 |
| RefSeq identity: |
NM_001127698 |
| Classification: |
Kazal type , Serine peptidase inhibitors |
| Havana BLAST/BLAT: |
OTTHUMG00000134305 |
| Locus Specific Databases: |
SPINK5base: Mutation registry for Netherton syndrome LRG_110 |